Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:36 PM
Study NCT ID:
NCT00065351
Status:
COMPLETED
Last Update Posted:
2019-11-12
First Post:
2003-07-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2006-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2003-07-21
First Submit QC Date:
None
Study First Post Date:
2003-07-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-07
Last Update Post Date:
2019-11-12
Last Update Post Date Type:
ACTUAL